Italia

7 nuovi farmaci in commercio

Nuove specialitÓ medicinali:Pazenir, Ruxience, Takhzyro.3 nuovi farmaci equivalenti

Nuove specialità medicinali
PAZENIR 1 flaconcino EV polv 100 mg 5 mg/ml paclitaxel albumina
RATIOPHARM GMBH AIC:047855010 249,24€ H/OSP in commercio dal:03/05/2021

RUXIENCE 1 flaconcino EV 100 mg 10 ml 10 mg/ml rituximab
PFIZER AIC:048720015 413,48€ H/OSP in commercio dal:12/05/2021

RUXIENCE 1 flaconcino EV 500 mg 50 ml 10 mg/ml rituximab
PFIZER AIC:048720027 1.653,59€ H/OSP in commercio dal:12/05/2021

TAKHZYRO 1 siringa preriemp SC 300 mg 2 ml lanadelumab
SHIRE AIC:047417047 23.379,57€ A/RR in commercio dal:06/05/2021


Nuovi farmaci equivalenti 
CEFUROXIMA MYLAN 12 cpr riv 250 mg acetossietilcefuroxima
MYLAN AIC:048025035 5,60€ A/RR in commercio dal:06/05/2021

FLUTICASONE DOC 120 erogazioni 250 mcg fluticasone propionato
DOC AIC:043082027 29,18€ A/RR in commercio dal:06/05/2021

TADALAFIL TEVA 12 cpr riv 20 mg tadalafil
TEVA AIC:043274416 72,00€ A/RR in commercio dal:07/05/2021

SEZIONE DOWNLOAD